Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-07-24Clinical Trial Update: Analysis of Biopsies From the Upper Gastrointestinal Tract
This clinical trial update summarizes an analysis of biopsies from the upper gastrointestinal tract for gastroesophageal reflux disease and …
-
CLINICAL_TRIALS trial_result · 2012-07-24Clinical Trial Update: COPD Patients Diagnosed With GERD,COPD Exacerbations After Treatment With High Dose PPI [NA]
This terminated study investigated high-dose proton pump inhibitors in COPD patients with gastroesophageal reflux disease and reported COPD …
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: Effect of Nortriptyline in Cortical Representation of Heartburn in Nonerosive Reflux Disease (NERD) Patients [Phase 3]
A Phase 3 clinical trial evaluating nortriptyline's effect on the cortical representation of heartburn in nonerosive reflux disease has comp…
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD) [Phase 2]
Phase 2 trial evaluating ADX10059 as an add-on therapy to proton pump inhibitors for gastroesophageal reflux disease has completed.
-
CLINICAL_TRIALS withdrawal · 2012-07-11Clinical Trial Update: Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain [Phase 4]
Phase 4 trial of Dexilant (dexlansoprazole) for gastroesophageal reflux disease-related non-cardiac chest pain was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-06Clinical Trial Update: Prevalence of Gastroesophageal Reflux Disease in Peritoneal Dialysis and Hemodialysis Patients
This clinical trial update reports on the prevalence of gastroesophageal reflux disease among patients on peritoneal dialysis and hemodialys…
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux Disease [Phase 3]
A Phase 3 trial comparing pantoprazole magnesium 40 mg to esomeprazole 40 mg in patients with erosive gastroesophageal reflux disease has co…
-
FDA approval · 2012-06-13FDA Approved: FAMOTIDINE — Supplemental Application (Carlsbad Technology, Inc)
FDA approved a supplemental application for famotidine from Carlsbad Technology, Inc.
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg. [Phase 1]
Open-label Phase 1 study evaluating 24-hour gastric pH on days 1, 2, and 7 after once-daily Lavoltidine 40 mg.
-
CLINICAL_TRIALS trial_result · 2012-05-25Clinical Trial Update: Follow-up of Patients Operated Upon for Type II-IV Hiatal Hernia
Follow-up results from patients operated for Type II-IV hiatal hernia; the study conducted by University of Bologna is completed.
-
FDA label_change · 2012-05-18FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for Pantoprazole Sodium (Lannett Company) under ANDA 078281, signaling changes to the labeling f…
-
FDA approval · 2012-05-18FDA Approved: BASIC CARE LANSOPRAZOLE — Original Application (Amazon.com Services LLC)
FDA approved a generic lansoprazole product, BASIC CARE LANSOPRAZOLE, under an original application by Amazon.com Services LLC. This provide…
-
FDA approval · 2012-05-18FDA Approved: LANSOPRAZOLE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original ANDA for lansoprazole from Dr. Reddy's Laboratories, authorizing a generic lansoprazole product.
-
CLINICAL_TRIALS research · 2012-05-16Clinical Trial Update: Effect of Repeated Doses of YF476, Omeprazole and Placebo on Stomach Acidity in Healthy Volunteers [Phase 1]
Phase 1 trial evaluating the effects of repeated doses of YF476 and omeprazole (vs placebo) on stomach acidity in healthy volunteers; the st…
-
FDA approval · 2012-05-11FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) from Wyeth Pharmaceuticals (Pfizer).
-
FDA approval · 2012-05-10FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for PROTONIX I.V. (pantoprazole sodium) from Wyeth Pharmaceuticals (Pfizer).
-
CLINICAL_TRIALS trial_result · 2012-05-10Clinical Trial Update: Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease
This completed AstraZeneca-sponsored clinical trial assessed symptom control and the impact on daily life in patients with gastroesophageal …
-
FDA approval · 2012-05-08FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved Waylis Therapeutics LLC's supplemental application for ACIPHEX (rabeprazole sodium).
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341) [Phase 3]
Phase 3 trial BY1023/M3-341 evaluated pantoprazole for treating symptoms of acid reflux disease in adults; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343) [Phase 3]
Phase 3 clinical trial assessing symptom outcomes in adults with erosive GERD or endoscopic-negative GERD after pantoprazole treatment; the …
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339) [Phase 3]
Phase 3 trial evaluating the efficacy of pantoprazole for gastroesophageal reflux symptoms in adults 18 and older; study completed.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708) [Phase 3]
Phase 3 long-term trial of pantoprazole in patients with chronic acid-related symptoms (GERD and peptic ulcers) has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004) [Phase 3]
This Phase 3 trial update reports on the efficacy of pantoprazole in adults with non-erosive reflux disease or gastroesophageal reflux disea…
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506) [Phase 4]
Phase 4 clinical trial update evaluating a questionnaire after pantoprazole treatment at full and half doses in adults with gastroesophageal…
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340) [Phase 4]
A Phase 4 trial evaluated the minimal clinically important difference in symptom relief after pantoprazole treatment in patients with gastro…